New patent expiration for Mallinckrodt Hosp drug OFIRMEV – DrugPatentWatch

Copyright © DrugPatentWatch. Originally published at New patent expiration for Mallinckrodt Hosp drug OFIRMEV

Annual Drug Patent Expirations for OFIRMEV

Ofirmev is a drug marketed by Mallinckrodt Hosp and is included in one NDA. It is available from two suppliers. There are five patents…